Recomendaciones SER sobre la utilización de fármacos biológicos en el síndrome de Sjögren primario-Reference-Cited by-同舟云学术

Recomendaciones SER sobre la utilización de fármacos biológicos en el síndrome de Sjögren primario

Published:2019-11 Issue:6 Volume:15 Page:315-326
ISSN:1699-258X
Container-title:Reumatología Clínica
language:es
Short-container-title:Reumatología Clínica

Author:

Andréu Sánchez José Luis,Fernández Castro Mónica,del Campo Fontecha Petra Díaz,Corominas Héctor,Narváez García Francisco Javier,Gómez de Salazar José Rosas,Rua-Figueroa Íñigo,Abad Hernández Miguel Ángel,Álvarez Rivas María Noelia,Montes Javier del Pino,Francisco Hernández Félix Manuel,Gantes Pedraza María Ángeles,Greco Merino Martín Gerardo,Hernández María Vanesa,Navarro Compán María Victoria,Solarte Juan Alberto Paz,Romero Bueno Fredeswinda I.,Park Hye Sang,Sivera Mascaró Francisca

Publisher

Elsevier BV

Subject

Rheumatology

Reference77 articles.

1. Sjogren syndrome;Brito-Zeron;Nat Rev Dis Primers.,2016

2. Primary Sjogren's syndrome: clinical phenotypes, outcome and the development of biomarkers;Goules;Immunol Res.,2017

3. Autoantibodies in Sjogren's Syndrome;Fayyaz;Rheum Dis Clin North Am.,2016

4. Epidemiology of primary Sjogren's syndrome: A systematic review and meta-analysis;Qin;Ann Rheum Dis.,2015

5. Primary Sjogren syndrome in Spain: Clinical and immunologic expression in 1010 patients;Ramos-Casals;Medicine (Baltimore).,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Future of Targeted Treatment of Primary Sjögren’s Syndrome: A Focus on Extra-Glandular Pathology;International Journal of Molecular Sciences;2022-11-16

2. Efficacy and safety of biological drugs in interstitial lung disease associated with connective tissue diseases;Expert Opinion on Drug Safety;2021-09-01

3. Protocolo diagnóstico y tratamiento de la astenia en las enfermedades autoinmunes;Medicine - Programa de Formación Médica Continuada Acreditado;2021-05

4. Síndrome de Sjögren;Medicine - Programa de Formación Médica Continuada Acreditado;2021-04

5. Tailoring biologic therapy for real-world rheumatoid arthritis patients;Expert Opinion on Biological Therapy;2020-11-15